77 research outputs found
Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung ultrasound study
BACKGROUND: B-lines evaluated by lung ultrasound (LUS) are the sonographic sign of pulmonary congestion, a major predictor of morbidity and mortality in patients with heart failure (HF). Our aim was to assess the prognostic value of B-lines at discharge to predict rehospitalization at 6 months in patients with acute HF (AHF).
METHODS: A prospective cohort of 100 patients admitted to a Cardiology Department for dyspnea and/or clinical suspicion of AHF were enrolled (mean age 70 ± 11 years). B-lines were evaluated at admission and before discharge. Subjects were followed-up for 6-months after discharge.
RESULTS: Mean B-lines at admission was 48 ± 48 with a statistically significant reduction before discharge (20 ± 23, p 15) (log rank χ(2) 20.5, p 15 before discharge (hazard ratio [HR] 11.74; 95 % confidence interval [CI] 1.30-106.16) was an independent predictor of events at 6 months.
CONCLUSIONS: Persistent pulmonary congestion before discharge evaluated by ultrasound strongly predicts rehospitalization for HF at 6-months. Absence or a mild degree of B-lines identify a subgroup at extremely low risk to be readmitted for HF decompensation
The five-point Likert scale for dyspnea can properly assess the degree of pulmonary congestion and predict adverse events in heart failure outpatients
OBJECTIVES: Proper assessment of dyspnea is important in patients with heart failure. Our aim was to evaluate the use of the 5-point Likert scale for dyspnea to assess the degree of pulmonary congestion and to determine the prognostic value of this scale for predicting adverse events in heart failure outpatients. METHODS: We undertook a prospective study of outpatients with moderate to severe heart failure. The 5-point Likert scale was applied during regular outpatient visits, along with clinical assessments. Lung ultrasound with ≥15 B-lines and an amino-terminal portion of pro-B-type natriuretic peptide (NT-proBNP) level >;1000 pg/mL were used as a reference for pulmonary congestion. The patients were then assessed every 30 days during follow-up to identify adverse clinical outcomes. RESULTS: We included 58 patients (65.5% male, age 43.5±11 years) with a mean left ventricular ejection fraction of 27±6%. In total, 29.3% of these patients had heart failure with ischemic etiology. Additionally, pulmonary congestion, as diagnosed by lung ultrasound, was present in 58% of patients. A higher degree of dyspnea (3 or 4 points on the 5-point Likert scale) was significantly correlated with a higher number of B-lines (p = 0.016). Patients stratified into Likert = 3-4 were at increased risk of admission compared with those in class 1-2 after adjusting for age, left ventricular ejection fraction, New York Heart Association functional class and levels of NT-proBNP >;1000 pg/mL (HR = 4.9, 95% CI 1.33-18.64, p = 0.017). CONCLUSION: In our series, higher baseline scores on the 5-point Likert scale were related to pulmonary congestion and were independently associated with adverse events during follow-up. This simple clinical tool can help to identify patients who are more likely to decompensate and whose treatment should be intensified
GAPS-megacities: A new global platform for investigating persistent organic pollutants and chemicals of emerging concern in urban air
A pilot study was initiated in 2018 under the Global Atmospheric Passive Sampling (GAPS) Network named GAPS-Megacities. This study included 20 megacities/major cities across the globe with the goal of better understanding and comparing ambient air levels of persistent organic pollutants and other chemicals of emerging concern, to which humans residing in large cities are exposed. The first results from the initial period of sampling are reported for 19 cities for several classes of flame retardants (FRs) including organophosphate esters (OPEs), polybrominated diphenyl ethers (PBDEs), and halogenated flame retardants (HFRs) including new flame retardants (NFRs), tetrabromobisphenol A (TBBPA) and hexabromocyclododecane (HBCDD). The two cities, New York (USA) and London (UK) stood out with ∼3.5 to 30 times higher total FR concentrations as compared to other major cities, with total concentrations of OPEs of 15,100 and 14,100 pg/m, respectively. Atmospheric concentrations of OPEs significantly dominated the FR profile at all sites, with total concentrations in air that were 2–5 orders of magnitude higher compared to other targeted chemical classes. A moderately strong and significant correlation (r = 0.625, p < 0.001) was observed for Gross Domestic Product index of the cities with total OPEs levels. Although large differences in FR levels were observed between some cities, when averaged across the five United Nations regions, the FR classes were more evenly distributed and varied by less than a factor of five. Results for Toronto, which is a ‘reference city’ for this study, agreed well with a more in-depth investigation of the level of FRs over different seasons and across eight sites representing different urban source sectors (e.g. traffic, industrial, residential and background). Future sampling periods under this project will investigate trace metals and other contaminant classes, linkages to toxicology, non-targeted analysis, and eventually temporal trends. The study provides a unique urban platform for evaluating global exposome.A global study across 20 megacities/major cities reporting urban air concentrations of flame retardants and plasticizers.Authors thank the United Nations Environment Programme
(UNEP) and the Chemicals Management Plan (CMP) for financial
support. The worldwide implementation of the Global Monitoring
Plan is made possible thanks to the generous contributions to the
Stockholm Convention Voluntary Trust Fund from the Governments
of Japan, Norway, Sweden, and through the European
Commission’s Thematic Programme for Environment andSustainable Management of Natural Resources, including Energy
(ENRTP). Further, the contribution of the projects to support POPs
monitoring activities in regions, funded through the Global Environment
Facility (GEF) and the Strategic Approach to International
Chemicals Management (SAICM), is greatly acknowledged. Monitoring
activities and data collection and analysis are implemented
in the five UN regions in cooperation with strategic partners and
through the involvement of Regional Organization Groups and
Global Coordination Group.
We also thank Yasuyuki Shibata and Yoshikatsu Takazawa
(Tokyo, Japan); Juan Mu~noz-Arnanz (Madrid, Spain) and Dilek
€Ozkan and Sinan Kızıltug (_Istanbul, Turkey) for their help and
assistance in the sampling campaign
Stress echo 2020: The international stress echo study in ischemic and non-ischemic heart disease
Abstract
Background
Stress echocardiography (SE) has an established role in evidence-based guidelines, but recently its breadth and variety of applications have extended well beyond coronary artery disease (CAD). We lack a prospective research study of SE applications, in and beyond CAD, also considering a variety of signs in addition to regional wall motion abnormalities.
Methods
In a prospective, multicenter, international, observational study design, > 100 certified high-volume SE labs (initially from Italy, Brazil, Hungary, and Serbia) will be networked with an organized system of clinical, laboratory and imaging data collection at the time of physical or pharmacological SE, with structured follow-up information. The study is endorsed by the Italian Society of Cardiovascular Echography and organized in 10 subprojects focusing on: contractile reserve for prediction of cardiac resynchronization or medical therapy response; stress B-lines in heart failure; hypertrophic cardiomyopathy; heart failure with preserved ejection fraction; mitral regurgitation after either transcatheter or surgical aortic valve replacement; outdoor SE in extreme physiology; right ventricular contractile reserve in repaired Tetralogy of Fallot; suspected or initial pulmonary arterial hypertension; coronary flow velocity, left ventricular elastance reserve and B-lines in known or suspected CAD; identification of subclinical familial ..
DOENÇAS DIAGNOSTICADAS PELO LABORATÓRIO DE PATOLOGIA VETERINÁRIA EM 2017
Este trabalho apresenta a casuística de diagnósticos no ano de 2017 do Laboratório de Patologia Veterinária do IFC Campus Concórdia. Foram 230 diagnósticos em bovinos, 32 em ovinos e 93 em suínos, totalizando 355. Destes, 247 (69,6%) foram através de necropsias e 108 (30,4%) através de amostras formolizadas enviadas por veterinários. Em bovinos as doenças mais incidentes foram anaplasmose e babesiose com 11 casos cada (4,8%); endocardite com 7 casos (3,0%); hemoncose com 6 casos (2,6%) e retículo pericardite traumática com 6 casos (2,6%). Já em ovinos foi hemoncose com 5 casos (15,7%) e suínos doença de Glässer e colibacilose com 6 casos cada (6,4%).
Spatial variability and temporal trends of HCH and DDT in soils around Beijing Guanting Reservoir, China
Embebição de sementes e aplicação foliar com cloreto de mepiquat no crescimento e produção do algodoeiro
Caracterização de lavouras cafeeiras, utilizando técnicas de geoprocessamento e sensoriamento remoto, no município de Umuarama - PR
- …